Stockholders' Equity Attributable to Parent in USD of SQZ Biotechnologies Co from Q4 2018 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
SQZ Biotechnologies Co quarterly Stockholders' Equity Attributable to Parent history and change rate from Q4 2018 to Q3 2023.
  • SQZ Biotechnologies Co Stockholders' Equity Attributable to Parent for the quarter ending 30 Sep 2023 was $1.88M, a 97.3% decline year-over-year.
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Change (%)

SQZ Biotechnologies Co Quarterly Stockholders' Equity Attributable to Parent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2023 $1.88M -$66.7M -97.3% 30 Sep 2023 10-Q 08 Nov 2023
Q2 2023 $24.5M -$63.7M -72.2% 30 Jun 2023 10-Q 08 Nov 2023
Q1 2023 $40.2M -$64.8M -61.7% 31 Mar 2023 10-Q 10 Aug 2023
Q4 2022 $57.1M -$66.8M -53.9% 31 Dec 2022 10-Q 08 Nov 2023
Q3 2022 $68.6M -$64.6M -48.5% 30 Sep 2022 10-Q 08 Nov 2023
Q2 2022 $88.2M -$64.5M -42.2% 30 Jun 2022 10-Q 08 Nov 2023
Q1 2022 $105M -$64.4M -38% 31 Mar 2022 10-Q 10 Aug 2023
Q4 2021 $124M -$3.22M -2.53% 31 Dec 2021 10-Q 08 Nov 2023
Q3 2021 $133M +$237M 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 $153M +$245M 30 Jun 2021 10-Q 09 Nov 2022
Q1 2021 $169M +$253M 31 Mar 2021 10-Q 04 Aug 2022
Q4 2020 $127M +$201M 31 Dec 2020 10-K 22 Mar 2023
Q3 2020 -$104M -$40.2M -62.9% 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$92.6M -$36M -63.7% 30 Jun 2020 10-Q 10 Nov 2021
Q1 2020 -$83.3M 31 Mar 2020 10-Q 04 Aug 2021
Q4 2019 -$73.5M -$30M -68.8% 31 Dec 2019 10-K 16 Mar 2022
Q3 2019 -$63.9M 30 Sep 2019 10-Q 10 Dec 2020
Q2 2019 -$56.5M 30 Jun 2019 10-Q 10 Dec 2020
Q4 2018 -$43.5M 31 Dec 2018 10-K 18 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.